Took is as they’re simply adding 42 day mortalit
Post# of 148181
(Total Views: 559)
Posted On: 10/20/2020 11:26:26 PM
Took is as they’re simply adding 42 day mortality to Secondary Endpoint. The big takeaway today was NO CHANGE to primary endpoint or N (# patients)... this additional data can improve the case for Leronlimab approval by showing that additional data point.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼